Immunomodulating Potential of Ekebergia capensis in Murine Schistosoma mansoni Juvenile and Adult Infection

References (52)

1. 1 Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni [DOI]
2. 2 Diagnosis and management of schistosomiasis [DOI]
3. 3 Praziquantel, a new broad-spectrum antischistosomal agent [DOI]
4. 4 Susceptibility or resistance of praziquantel in human schistosomiasis: a review [DOI]
5. 5 Immunopathogenesis of schistosomiasis [DOI]
6. 6 IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis [DOI]
7. 7 CD11c depletion severely disrupts Th2 induction and development in vivo [DOI]
8. 8 Antischistosomal drugs: Past, present … and future? [DOI]
9. 9 Resistance of Schistosoma mansoni to praziquantel: is there a problem? [DOI]
10. 10 Schistosomiasis: challenges for control, treatment and drug resistance [DOI]
11. 11 Clinical and Immunologic Evaluation of 31 Patients with Acute Schistosomiasis mansoni [DOI]
12. 12 Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal [DOI]
13. 13 Macrophage activation governs schistosomiasis‐induced inflammation and fibrosis [DOI]
14. 14 Acute schistosomiasis, a diagnostic and therapeutic challenge [DOI]
15. 15 Multi-Component Herbal Products in the Prevention and Treatment of Chemotherapy-Associated Toxicity and Side Effects: A Review on Experimental and Clinical Evidences [DOI]
16. 16 Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni [DOI]
17. 17 Approaches to advance drug discovery for neglected tropical diseases [DOI]
18. 18 Antischistosomal Agents: State of Art and Perspectives [DOI]
19. 19 Bioactive Natural Products for Pharmaceutical Applications [DOI]
20. 20 Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice [DOI]
21. 21 Mesenchymal stem cells as a potential therapy for COVID-19 [DOI]
22. 22 Prevalence of schistosomiasis and associated risk factors among school children in Um-Asher Area, Khartoum, Sudan [DOI]
23. 23 Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy [DOI]
24. 24 The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. [DOI]
25. 25 Immunity induced by the radiation‐attenuated schistosome vaccine [DOI]
26. 26 Immunopathology of schistosomiasis: a cautionary tale of mice and men [DOI]
27. 27 IL-23 Is Required for the Development of Severe Egg-Induced Immunopathology in Schistosomiasis and for Lesional Expression of IL-17 [DOI]
28. 28 Ly6Chi Monocyte Recruitment Is Responsible for Th2 Associated Host-Protective Macrophage Accumulation in Liver Inflammation due to Schistosomiasis [DOI]
29. 29 Interleukin 10 (IL-10)–Producing CD1dhi Regulatory B Cells From Schistosoma Haematobium–Infected Individuals Induce IL-10–Positive T Cells and Suppress Effector T-Cell Cytokines [DOI]
30. 30 Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomes in sub-Saharan Africa: a systematic review [DOI]
31. 31 FDA-Approved Antiparasitic Drugs in the 21st Century: A Success for Helminthiasis? [DOI]
32. 32 Acute Schistosomiasis Outbreak: Clinical Features and Economic Impact [DOI]
33. 33 In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human Infections [DOI]
34. 34 The C-type Lectin Receptor-Driven, Th17 Cell-Mediated Severe Pathology in Schistosomiasis: Not All Immune Responses to Helminth Parasites Are Th2 Dominated [DOI]
35. 35 Immunomodulatory effects and structure-activity relationship of botanical pentacyclic triterpenes: A review [DOI]
36. 36 T‐bet protects against exacerbation of schistosome egg‐induced immunopathology by regulating Th17‐mediated inflammation [DOI]
37. 37 Efficiency of ginger (Zingbar officinale) against Schistosoma mansoni infection during host–parasite association [DOI]
38. 38 Drug-Induced Exposure of Schistosoma mansoni Antigens SmCD59a and SmKK7 [DOI]
39. 39 Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice [DOI]
40. 40 Advances in schistosomiasis drug discovery based on natural products. [DOI]
41. 41 Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.
42. 42 Cytokine Interaction and Immune Responses during Schistosoma mansoni Infection [DOI]
43. 43 Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.
44. 44 Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure [DOI]
45. 45 Schistosomiasis in travelers and immigrants [DOI]
46. 46 The immune-dependence of chemotherapy in experimental schistosomiasis [DOI]
47. 47 Study of the behavior of snails intermediate hosts of Schistosoma spp. under different maintenance conditions and their resistance to salinity in an african laboratory environment [DOI]
48. 48 Antischistosomal Activity of Azadirachta indica and Ekebergia capensis in Mice Infected with Schistosoma mansoni [DOI]
49. 49 Effect of garlic and neem leaf aqueous extracts on immune response of broilers to live Newcastle disease vaccine [DOI]
50. 50 Defeating Schistosomiasis [DOI]
51. 51 Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022 [DOI]
52. 52 Evaluation of the Anti-schistosomal Effects of Turmeric (Curcuma longa) Versus Praziquantel in Schistosoma mansoni Infected Mice

Cited by 0

No indexed citations yet.

Related research

• Prevalence of Schistosomia haematobium and Staphylococcus aureus among Pregnant Women in Akure — shares topic coverage
• Lipid Profile in School Children Infected with Urinary Schistosomiasis in Fante Akura-Yeji, Ghana — shares topic coverage
• Prevalence of Schistosomiasis among Primary School Children in Gadabuke District, Toto LGA, North Central Nigeria — shares topic coverage
• Environmental and Behavioral Determinants of Schistosomiasis in Bodo Community, Rivers State, Nigeria — shares topic coverage
• Hidden Burden: Schistosomiasis Prevalence and Risk Factors among Enrolled and Out-of-School Children in Kebbi State, Nigeria — shares topic coverage